Cutler Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$47K Buy
700
+500
+250% +$33.6K 0.02% 398
2023
Q4
$12K Sell
200
-1,800
-90% -$108K ﹤0.01% 953
2023
Q3
$90K Sell
2,000
-860
-30% -$38.7K 0.01% 576
2023
Q2
$160K Buy
2,860
+2,160
+309% +$121K 0.02% 383
2023
Q1
$31K Buy
+700
New +$31K ﹤0.01% 748
2022
Q4
Sell
-12,553
Closed -$820K 1849
2022
Q3
$820K Sell
12,553
-247
-2% -$16.1K 0.06% 186
2022
Q2
$777K Sell
12,800
-10,668
-45% -$648K 0.05% 207
2022
Q1
$1.47M Buy
23,468
+730
+3% +$45.8K 0.08% 155
2021
Q4
$1.72M Buy
22,738
+9,838
+76% +$745K 0.07% 178
2021
Q3
$1.44M Buy
12,900
+2,320
+22% +$260K 0.06% 189
2021
Q2
$1.71M Buy
10,580
+2,580
+32% +$417K 0.08% 179
2021
Q1
$974K Sell
8,000
-4,760
-37% -$580K 0.05% 277
2020
Q4
$1.95M Buy
12,760
+12,360
+3,090% +$1.89M 0.09% 130
2020
Q3
$33K Buy
+400
New +$33K ﹤0.01% 1009
2020
Q2
Sell
-800
Closed -$33K 1641
2020
Q1
$33K Sell
800
-1,300
-62% -$53.6K ﹤0.01% 877
2019
Q4
$127K Buy
+2,100
New +$127K 0.01% 630
2019
Q3
Hold
0
1582
2019
Q2
Hold
0
1670
2019
Q1
Hold
0
1607
2018
Q4
Hold
0
1714
2018
Q3
Hold
0
1709
2018
Q2
Sell
-6,097
Closed -$278K 1757
2018
Q1
$278K Buy
+6,097
New +$278K 0.02% 445
2017
Q4
Sell
-600
Closed -$10K 2223
2017
Q3
$10K Buy
600
+263
+78% +$4.38K ﹤0.01% 1892
2017
Q2
$5K Buy
+337
New +$5K ﹤0.01% 2391